Jointown Pharmaceutical Group   www.jztey.com

We strive to be the most professional health service platform in China

Jointown is a technology-driven comprehensive service provider for the full-chain pharmaceutical industry. The company is positioned in the broader health industry, with its main businesses encompassing six major areas: digital pharmaceutical distribution and supply chain operations, general agent brand promotion, pharmaceutical industry self-production and OEM, new retail and franchise store operations (C-end), medical health (C-end) and technology value-added services, digital logistics technology, and supply chain solutions. Jointown has taken the lead in the industry in implementing the transformation and upgrading from traditional pharmaceutical distribution to digitalization, platformization, and Internetization, achieving remarkable results. It has gradually transitioned from a single pharmaceutical distribution format to multiple formats such as pharmaceutical CSO, new pharmaceutical retail, and pharmaceutical industry.  

Jointown has established a "hundred-billion-level" pharmaceutical supply chain service platform, which is scarce in the industry. It has completed the business layout of full-category procurement, full-channel coverage, and full-scenario services. Relying on the resource advantages of the hundred-billion platform, it is fully committed to building the entire pharmaceutical industry chain and forming a new pattern of integrated development of "pharmaceutical distribution + multiple business formats". Centered around the six major business layouts, it further enhances the company's business growth points and gradually forms a comprehensive health service platform that is characterized by multiple business formats and platforms, integrating "wholesale and retail" and "B2C", serving both B-end and C-end users through a combination of online and offline services.

In 2026, the group established a new three-year strategy, centered around the "Four New and Two Transformations" (new products, new retail, new healthcare, new services, digitalization and intelligentization, and capitalization), to construct a clear and explicit path for business development and upgrading, jointly driving the group's high-quality growth. Jointown drives growth through business innovation, enhances quality and efficiency through digital control, and persists in seeking progress while maintaining stability to open up new horizons. In the future, Jointown will continue to implement a comprehensive service model of "pharmaceutical distribution + logistics and distribution + product promotion", grasp new market trends, ride the wave, and maintain a steady growth trend.

Beijing Jingfeng Pharmaceutical Group Co., Ltd.

Beijing Jingfeng Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of Jointown Pharmaceutical Group, specializes in the pharmaceutical industry, particularly in the production and operation of the healthcare sector. Its primary business encompasses the research and development, production, sales, and CMO/CDMO services of active pharmaceutical ingredients and pharmaceutical preparations. Jingfeng is on its way to becoming a modern pharmaceutical industrial enterprise with multiple dosage forms, diverse product categories, and significant scale. It has been recognized with titles such as National High-tech Enterprise and Beijing "Specialized, Fine, Unique, and Innovative"Enterprise.

The company's headquarters is located in the Biomedical Industry Base of Zhongguancun Science and Technology Park in Daxing District, Beijing, and was completed in October 2017, covering an area of 106.20 acres with a total project investment of 700 million yuan. Leveraging the advantages of the headquarters, Jingfeng Group has established three major production bases in Beijing, Hebei, and Shandong, possessing 15 dosage forms and over 30 pharmaceutical production lines certified by China's CFDA. The dosage forms include tablets, capsules, granules, solutions, ointments, liniments, sticks, gels, aerosol sprays, etc. Additionally, the company has production lines for special preparations such as topical steroids and anti-tumor drugs, along with 30 supporting active pharmaceutical ingredient (API) production lines. It can achieve an annual production capacity of 50 billion tablets, 5 billion capsules, 500 million granules, 1 billion solutions, 1 billion ointments, 3,000 tons of APIs, etc. The products cover a wide range of dosage forms, varieties, quality, production capacity, and therapeutic areas.

Subordinate enterprise of Jingfeng Group
Jingfeng Group has established production bases for pharmaceutical preparations and active pharmaceutical ingredients, pharmaceutical commercial companies, and Jointown incubators in Beijing, Hebei, Shandong, and other regions.

Jingfeng Hebei Manufactory

Beijing Jingfeng Pharmaceutical (Hebei) Co., Ltd. was established in June 2016 and is located in Fengnan District, Tangshan City, Hebei Province; In strict accordance with the national GMP standards, new hormone production workshops, non-hormone production workshops, sterile preparation workshops and high-end laboratories and other supporting facilities, including 10 non-hormone workshop tincture production lines, ointment production lines, cream production lines, and solution production lines.

Main business

Existing creams (including hormones), ointments (including hormones), tinctures (including hormones), solutions (including hormones), ointments, eye drops, gels and enemas, etc.

It has undertaken 20 advanced CMO and CDMO projects. It has obtained 17 domestic patents.

Jingfeng Shandong Manufactory

Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd. is located in the Baita Industrial Park, Boshan District, Zibo City. It has newly constructed a preparation workshop, an active pharmaceutical ingredient workshop, a power workshop, as well as auxiliary facilities such as a quality inspection center, environmental protection facilities, and noise reduction facilities, all in strict accordance with national GMP standards. The company boasts over 170 sets of preparation equipment, more than 20 sets of paste equipment, and over 50 sets of environmental protection equipment. Currently, there are four GMP-compliant preparation workshops (including solid preparations, cephalosporin preparations, and topical preparations) and three GMP-compliant active pharmaceutical ingredient workshops.

Main business

At present, there are 133 specifications and 25 special APIs in tablets (including cephalosporins), capsules (including cephalosporins), creams (including hormones), liniments, patches, ointments, gels and APIs. It covers the fields of psychiatric diseases, diabetes, antifungals, cardiovascular and cerebrovascular drugs, and antidotes. 

Shandong Jingfeng Pharmaceutical Co., Ltd

Shandong Jingfeng Pharmaceutical Co., Ltd. was established on November 2, 2016. It is a pharmaceutical wholesale company jointly invested and established by Beijing Jingfeng Pharmaceutical Group Co., Ltd., Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd., and Beijing Jingfeng Pharmaceutical (Hebei) Co., Ltd, Located at No. 6 Chuangye Avenue, Baita Town, Boshan District, Zibo City, Shandong Province, with a registered capital of 30 million yuan, it covers an area of over 30,000 square meters, with a total warehouse area of 10,054 square meters, a shaded warehouse area of 7,467 square meters, a normal temperature warehouse area of 2,384 square meters, and a cold storage area of 203 square meters.

Main business

Pharmaceutical wholesale, medical device operation, pharmaceutical import and export, etc.

Beijing Jointown Technology Incubator Co., Ltd

Jointown Technology Incubator Co., Ltd. was established in August 2004 and is located in Fengtai Park, Zhongguancun Science and Technology Park. Relying on the resources of hundreds of thousands of industrial clusters and upstream and downstream ecological industrial chains in the fields of pharmaceutical research and development, pharmaceutical logistics, production, sales, e-commerce, and market sales of Jointown Group, it has formed an industrial chain-style incubation service model of "professional technology platform + industrial ecosystem aggregation + early-stage incubation investment + market transformation services". Currently, it has obtained the standard-level certification of technology enterprise incubator from the Ministry of Industry and Information Technology, as well as qualifications such as Zhongguancun Hard Technology Incubator and user of innovation vouchers from the Capital Science and Technology Condition Platform of the Municipal Science and Technology Commission. It has incubated a total of 145 hard technology enterprises, cultivated 8 listed companies, 24 specialized, refined, unique, and innovative enterprises, and 71 high-tech enterprises. The quality of both incubating and graduated enterprises is leading.

Main business

Investment incubation services (business registration, project service application, achievement transformation services), professional platform services (drug research and development, drug production, drug testing services), business services, public system services, etc.